A recent study found an experimental drug from Incyte to be effective in treating advanced myelofibrosis. The treatment targets a specific protein mutation and showed significant improvements in disease symptoms, giving the company hope to develop new medicines as its current blockbuster is set to lose patent protection in 2028.
Source: https://www.statnews.com/2025/12/07/incyte-results-myelofibrosis-treatment-ash-2025